Industry News
The latest medical device regulatory news, clinical trials, and market insights
New Clinical Study Seeks Optimal Inspiratory Muscle Training for ICU Patients
The Royal Brompton & Harefield NHS Foundation Trust has announced a new clinical trial focused on determining the ideal dosage…
Clinical Trial Investigates Supplements for Supporting Men’s Health – Regulatory Insights
Efforia, Inc has initiated clinical trials of Heart and Soil’s Whole Package supplement, aiming to evaluate potential benefits for men’s…
Exploring Cognitive Impacts of Auricular Vagus Nerve Stimulation: New Clinical Study Announced
A new clinical trial focusing on the effects of transcutaneous auricular vagus nerve stimulation (taVNS) on cognitive performance has been…
Medicine Safety Alert: Baclofen 10mg Tablets Missing Correct Patient Safety Information
A safety advisory has been issued for Baclofen 10mg tablets, manufactured by Special Concept Development UK Limited. Regulatory authorities have…
Regulatory Update: MHRA Highlights November 2025’s Key Safety Insights for Medicines and Devices
The Medicines and Healthcare products Regulatory Agency (MHRA) has issued its latest safety roundup for November 2025, aimed at providing…
FDA Issues Serious Correction Notification for BD Alaris Pump Modules Due to Safety Risks
The United States Food and Drug Administration (FDA) has released an updated correction notification for BD Alaris pump modules. These…
Cardio Intelligence Closes Series B First Tranche to Drive Product Expansion and Overseas Growth
Meta description: AI-driven medical device company Cardio Intelligence has completed the first close of its Series B round, securing strategic…
Important Patient-Level Recall: Algifor Junior Suspension 200 ml and Algifor Dolo Junior Suspension 200 ml
Swissmedic issues a patient-centric recall for specific batches of Algifor Junior Suspension 200 ml and Algifor Dolo Junior Suspension 200…
Swissmedic Announces New Therapeutic Indication for Tepkinly®
Swissmedic has announced an update to the therapeutic indications for Tepkinly®. This regulatory approval marks an extension of the product’s…
Swissmedic Approves Enhertu® for Extended Therapeutic Indications
Swissmedic has granted authorization for the extension of therapeutic indications for Enhertu® as of November 28, 2025. This update marks…
Temporary Authorization Alert: Ringerfundin B. Braun Infusion Solution Distribution Update
Swissmedic, the Swiss Agency for Therapeutic Products, has granted a temporary approval for the distribution of Ringerfundin B. Braun Infusion…
Swissmedic Spotlights Personnel Roles: Essential Update for Teams
On November 28, 2025, Swissmedic released details regarding changes in personnel requirements within its Abteilung Personal und Organisation department. This…